Adar1 Capital Management, LLC Equillium, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 7,318 shares of EQ stock, worth $5,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,318
Previous 140,775
94.8%
Holding current value
$5,049
Previous $97.6 Million
93.76%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.07 Million0.88% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.07 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$580,9440.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$387,9711.86% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny321KShares$221,6090.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $23.7M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...